Pharmaceutical compositions of lithium compounds to treat presenile or senile dementia
US4753964A · kind A · utility
11Cited by
2References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 27, 1987 |
| Grant date | Jun 28, 1988 |
| Priority date | — |
| Expiry date | Jan 27, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the treatment of presenile or sensile dementia and in particular to the treatment of Alzheimer's disease. It is proposed that such conditions may be combatted or their effects alleviated by the administration of a physiologically acceptable lithium compound and/or of an essential fatty acid or a physiologically acceptable salt thereof and there are described herein methods of treatment of such conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.